Hexacosanoic acid

Hexacosanoic acid is a very long-chain fatty acid. Abnormally elevated levels of Hexacosanoic acid are closely associated with various diseases, such as X-linked adrenoleukodystrophy, adrenomyeloneuropathy, atherosclerosis, and dementia[1][2][3].

Product Specifications

CAS Number

[506-46-7]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Hexacosanoic_acid.html

Purity

98.15

Solubility

THF : 5.56 mg/mL (ultrasonic)

Smiles

CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O

Molecular Formula

C26H52O2

Molecular Weight

396.69

Precautions

H302, H315, H319, H335

References & Citations

[1]Yamamoto Y, et al. Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid.|[2]Zarrouk A, et al. Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia. J Alzheimers Dis. 2015;44 (4) :1349-59. |[3]Marchetti D P, et al. Increased levels of hexacosanoic acid in the brain of Wistar rats: a behavioral study. Clinical and biomedical research. Porto Alegre. Vol. 40, n. 3 (2020), p. 161-166, 2020.